1952.HKConferences•prnewswire•August 25, 2025 at 12:55 PM

Everest Medicines Announces Participation in September Investor Conferences

Sentiment:Negative (30)

Summary

SHANGHAI, Aug. 25, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 25, 2025 by prnewswire